Journal of Viral Hepatitis

Cover image for Vol. 15 Issue 9

September 2008

Volume 15, Issue 9

Pages 623–698

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study (pages 634–640)

      Thu-Ha Nguyen, Philip Jacobs, Anita Hanrahan, Nonie Fraser-Lee, Winnie Wong, Bonita Lee and Arto Ohinmaa

      Article first published online: 23 APR 2008 | DOI: 10.1111/j.1365-2893.2008.00985.x

      • image
    2. Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin (pages 641–645)

      O. Weiland, A. Hollander, L. Mattsson, H. Glaumann, K. Lindahl, R. Schvarcz, G. Lindh, R. Enquist and A. Quist

      Article first published online: 27 MAY 2008 | DOI: 10.1111/j.1365-2893.2008.00999.x

      • image
      • image
    3. Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved? (pages 646–650)

      G. Tarantino, V. Basile, P. Conca, M. Ariello, M. N. D. Di Minno, A. Romano, A. Gentile and D. Capone

      Article first published online: 27 MAY 2008 | DOI: 10.1111/j.1365-2893.2008.01002.x

    4. Correlation of serum ribavirin concentration with pretreatment renal function estimates in patients with chronic hepatitis C receiving combination antiviral therapy with peginterferon and ribavirin (pages 651–658)

      H. Toyoda, T. Kumada, S. Kiriyama, Y. Sone, M. Tanikawa, Y. Hisanaga, A. Kanamori, H. Atsumi, S. Nakano, T. Arakawa, T. Honda, K. Hayashi, Y. Katano and H. Goto

      Article first published online: 10 JUL 2008 | DOI: 10.1111/j.1365-2893.2008.01004.x

      • image
      • image
      • image
    5. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C (pages 659–665)

      T.-M. Scherzer, K. R. Reddy, F. Wrba, H. Hofer, K. Staufer, P. Steindl-Munda, A. Gangl and P. Ferenci

      Article first published online: 10 JUL 2008 | DOI: 10.1111/j.1365-2893.2008.01006.x

      • image
      • image
      • image
    6. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection (pages 666–674)

      L. L. Schiavon, J. L. Narciso-Schiavon, R. J. Carvalho Filho, J. P. Sampaio, J. O. Medina-Pestana, V. P. Lanzoni, A. E. B. Silva and M. L. G. Ferraz

      Article first published online: 14 MAY 2008 | DOI: 10.1111/j.1365-2893.2008.00992.x

      • image
      • image
    7. Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN (pages 675–683)

      M. L. Op den Brouw, M. A. W. P. De Jong, I. S. Ludwig, R. G. Van Der Molen, H. L. A. Janssen, T. B. H. Geijtenbeek and A. M. Woltman

      Article first published online: 14 MAY 2008 | DOI: 10.1111/j.1365-2893.2008.00993.x

      • image
      • image
      • image
      • image
      • image
    8. Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study (pages 684–689)

      K. Luo, Q. Mao, P. Karayiannis, D. Liu, Z. Liu, Y. Zhou, X. Feng, Y. Zhu, Y. Guo, R. Jiang, F. Zhou, J. Peng and J. Hou

      Article first published online: 28 JUN 2008 | DOI: 10.1111/j.1365-2893.2008.00995.x

      • image
    9. The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use (pages 690–698)

      F.-C. Tseng, B. R. Edlin, M. Zhang, A. Kral, M. P. Busch, B. A. Ortiz-Conde, T. M. Welzel and T. R. O’Brien

      Article first published online: 27 MAY 2008 | DOI: 10.1111/j.1365-2893.2008.01005.x

      • image

SEARCH

SEARCH BY CITATION